BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1319508)

  • 21. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic parameters and their value in testicular tumors].
    Bürgler W; Jaeger P
    Urologe A; 1986 May; 25(3):157-9. PubMed ID: 3016965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are lymphangiograms necessary before placing patients with nonseminomatous testicular tumors on surveillance?
    Wishnow KI; Johnson DE; Tenney D
    J Urol; 1989 May; 141(5):1133-5. PubMed ID: 2540349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 25. Intratubular trophoblasts in the contralateral testis caused elevation of serum human chorionic gonadotropin following complete remission of stage II testicular tumor: a case report.
    Nitta S; Kawai K; Onozawa M; Ando S; Miyazaki J; Nagata C; Noguchi M; Yamasaki K; Uchida K; Iwamoto T; Nishiyama H
    Jpn J Clin Oncol; 2013 Jan; 43(1):83-6. PubMed ID: 23136239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Initial experience in laparoscopic retroperitoneal lymphadenectomy for the management of nonseminomatous testicular cancer].
    Sosa-Durán EE; Harp-Hasan ZA; García-Rodríguez FM; Soto AB; Delgado-Ochoa Mde L; Jiménez-Villanueva X
    Cir Cir; 2012; 80(5):442-7. PubMed ID: 23351448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stage II nonseminomatous germ cell tumors of the testis: an analysis of treatment options in patients with low volume retroperitoneal disease.
    Socinski MA; Garnick MB; Stomper PC; Fung CY; Richie JP
    J Urol; 1988 Dec; 140(6):1437-41. PubMed ID: 2848138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum tumor markers in the evaluation of male germ cell tumors.
    Barlow LJ; Badalato GM; McKiernan JM
    Nat Rev Urol; 2010 Nov; 7(11):610-7. PubMed ID: 21068762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consensus statement on circulating tumour markers and staging patients with germ cell tumours.
    Rustin GJ; Vogelzang NJ; Sleijfer DT; Nisselbaum JN
    Prog Clin Biol Res; 1990; 357():277-84. PubMed ID: 2170994
    [No Abstract]   [Full Text] [Related]  

  • 30. Value of tumor markers in nonseminomatous germ cell tumor of the testis.
    Kulkarni JN; Kamat MR
    Eur Urol; 1993; 24(2):166-71. PubMed ID: 7690705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical aspects in the treatment of patients with testicular cancer.
    Richie JP
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1127-42. PubMed ID: 1663937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Position of surveillance therapy in clinical stage I testicular non-seminoma].
    Thon WF; Sparwasser C; Gilbert P; Altwein JE
    Urol Int; 1987; 42(6):445-9. PubMed ID: 2834854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [CCAFU french national guidelines 2016-2018 on testicular germ cell tumors].
    Durand X; Fléchon A; Murez T; Rocher L; Camparo P; Morel-Journel N; Savoie PH; Ferretti L; Sèbe P; Méjean A
    Prog Urol; 2016 Nov; 27 Suppl 1():S147-S165. PubMed ID: 27846929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late Relapse of Nonseminomatous Germ Cell Tumor 24 Years Later.
    Riedinger CB; Labbate C; Werntz RP; Eggener SE
    Urology; 2018 Dec; 122():16-18. PubMed ID: 30170087
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors.
    Cost NG; Lubahn JD; Adibi M; Romman A; Wickiser JE; Raj GV; Sagalowsky AI; Margulis V
    J Urol; 2014 May; 191(5 Suppl):1485-90. PubMed ID: 24679874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical stage I nonseminomatous and mixed germ cell tumors of the testis. A clinicopathologic study of 93 patients on a surveillance protocol after orchiectomy alone.
    Dunphy CH; Ayala AG; Swanson DA; Ro JY; Logothetis C
    Cancer; 1988 Sep; 62(6):1202-6. PubMed ID: 2842034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of retroperitoneal metastases in early-stage nonseminomatous testicular cancer: analysis of different CT criteria.
    Stomper PC; Fung CY; Socinski MA; Jochelson MS; Garnick MB; Richie JP
    AJR Am J Roentgenol; 1987 Dec; 149(6):1187-90. PubMed ID: 2825494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease relapse in patients with stage I nonseminomatous germ cell tumor of the testis on active surveillance.
    Thompson PI; Nixon J; Harvey VJ
    J Clin Oncol; 1988 Oct; 6(10):1597-603. PubMed ID: 2459319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis of patients after retroperitoneal lymphadenectomy for clinical stage I nonseminomatous germ cell tumour of the testis.
    Hornák M; Zvara V; Ondrus D; Bárdos A
    Czech Med; 1987; 10(2):109-16. PubMed ID: 2820669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.